Sanofi-aventis and DNDi held a symposium on the implementation of a new artemisinin combination therapy (ACT) in African endemic countries. Over 120 attendees from NGOs, academia, and the pharmaceutical sector heard presentations by FACT project partners on ASAQ and ASMQ. In addition, DNDi also presented the ethical considerations of malaria field studies, and screening of natural products against infectious disease pathogens.
Monday, November 5, 10:45 am
Symposium: “Obligations to participants in research trials in developing countries”
Isabela Ribeiro, DNDi: “Addressing Ethical Considerations In Undertaking Malaria Field Studies in Developing Countries“
Tuesday, November 6, 2007, 10:15 am – 12:00 pm
sanofi-aventis/DNDi Symposium: “Implementation of a New ACT in African Endemic Countries: Opportunities and Challenges for Documenting Safety and Effectiveness in the Field”
Chairs: Francois Bompart, sanofi-aventis; Wilfred F Mbacham, University of Yaoundé, Cameroon
Wednesday, November 7, 9:20 am
Simon Croft will cover “Screening natural products against neglected infectious disease pathogens”
DNDi’s booth (#309)
